India’s pharmaceutical industry, ranked third worldwide in terms of volume, is the largest supplier of generic drugs and is well-regarded for the role it plays in making high-quality medicines and vaccines affordable to the global population. Fueled by domestic and foreign demand, the sector continues to grow; currently a US$50 billion industry, optimistic forecasts project the Indian pharmaceutical industry could reach US$150 billion within a decade.  

Global Business Reports presents a timely review and analysis of the current state of the industry, highlighting innovations throughout the pharmaceutical value chain and including insight into burgeoning subsectors of the life sciences such as nutraceuticals, digital health, and medical devices. Drawing from interviews conducted with over 60 industry leaders, the India Life Sciences 2023 report brings readers up to speed on the country’s key strengths and areas for development within a post-pandemic landscape.